Now Available:  HTG EdgeSeq PATH Assay

Now available in the U.S. and Europe the HTG EdgeSeq PATH Assay has been designed for retrospective gene expression profiling to complement traditional immunohistochemistry (IHC) testing by allowing investigators to assess mRNA expression of large numbers of biomarkers when formalin-fixed, paraffin-embedded (FFPE) sample availability is limited. The assay is designed to detect up to 470 mRNA targets, typically assessed by IHC. MORE

Products Designed For Walk-away Automation

The HTG EdgeSeq system is a fully automated sample and library preparation platform for targeted RNA sequencing that pairs HTG's extraction-free, high-specificity HTG EdgeSeq chemistry with the high sensitivity and dynamic range of next-generation sequencing (NGS). MORE

HTG Molecular: Where We Excel

  • Pharma CDx and Biomarkers
  • Molecular Diagnostics
  • Translational Medicine
  • Academic/Government Research

Key Differentiators 

  • Extraction-free chemistry
  • Wide variety of samples
  • Small sample input requirements
  • Automated workflow
  • Simplified data assembly

For Research Use Only. Not for use in diagnostic procedures.

In the U.S. and other applicable jurisdictions, HTG EdgeSeq and VERI/O are trademarks of HTG Molecular Diagnostics, Inc.  Any other trademarks or trade names used herein are the intellectual property of their respective owners.